Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03725449 · ClinicalTrials.gov registry record · NA

Internet-based Intervention for Skin Self-Examination in Participants With Increased Risk for Melanoma

A NA study of Melanoma and Health Status Unknown, sponsored by Rutgers, The State University of New Jersey.

Completed
Registry status
NA
Development phase
116
Enrollment target
1
Study location

NCT03725449 is a NA study of Melanoma and Health Status Unknown that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 116 participants, below the 706-participant average among 266 other Melanoma trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03725449, a NA study of Melanoma and Health Status Unknown, has completed, sponsored by Rutgers, The State University of New Jersey.

COMPLETED
Registry status
NA
Development phase
116 participants
Enrollment target
1
Study location

Study Summary

This trial studies an internet-based intervention for skin self-examination (SSE) in participants at increased risk for melanoma. Early detection of suspicious growths on the skin can be done by performing regular SSE checks. Using an internet-based intervention, such as mySmartCheck, may help to promote regular, thorough checks on the skin in individuals at increased risk for melanoma.

Interventions

  • OTHER Survey Administration
  • OTHER Best Practice
  • BEHAVIORAL mySmartCheck

Study Locations (1)

New Jersey

  • Rutgers Cancer Institute of New Jersey - New Brunswick

Trial Details

FieldValue
Enrollment Target 116 participants
Start Date 2018-11-03
Est. Completion 2020-08-29
Phase NA

What the Registry Record Tells You About NCT03725449

The ClinicalTrials.gov registry entry for NCT03725449 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 116 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 706-participant average among 266 other Melanoma trials with a reported enrollment target (84% lower). The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Melanoma appearing as the primary indexed condition, and to 3 interventions - of which Survey Administration is the first listed.

NCT03725449 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT03725449 about?

NCT03725449 is a clinical study titled "Internet-based Intervention for Skin Self-Examination in Participants With Increased Risk for Melanoma". This trial studies an internet-based intervention for skin self-examination (SSE) in participants at increased risk for melanoma. Early detection of suspicious growths on the skin can be done by performing regular SSE checks. Using an internet-based intervention, such as mySmartCheck, may help to pr...

What is the current status of trial NCT03725449?

This trial is currently completed. It is a NA study. The enrollment target is 116 participants. The study started on 2018-11-03. Estimated completion is 2020-08-29.

What conditions does trial NCT03725449 study?

This clinical trial studies the following conditions: Melanoma, Health Status Unknown, No Evidence of Disease, Dysplastic Nevus.

What interventions are being tested in trial NCT03725449?

The interventions under investigation include: Survey Administration (OTHER), Best Practice (OTHER), mySmartCheck (BEHAVIORAL).

Who is sponsoring clinical trial NCT03725449?

This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03725449 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Melanoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.